Page 17 - Access Scheme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dragonfly cannabis oil receives approval to enter the Australian market SYDNEY, July 7, 2021 /PRNewswire/ Dragonfly Biosciences Ltd ( Dragonfly ) is pleased to announce Dragonfly CBD oil products are approved for use by the Australian Government s Therapeutic Goods Administration ( TGA ). The products have been approved under the TGA s Special Access Scheme ( SAS ) making them immediately available to be prescribed by Australian health practitioners. Highlights: The success of Dragonfly CBD is built on a unique seed to shelf quality guarantee. Any Australian health practitioners prescribe Dragonfly CBD products. Dragonfly is an established global leader in CBD oil and topical products, a market that is experiencing rapid growth

United statesNew south walesUnited kingdomGiles raffertyKostenloser wertpapierhandelRegan saveallHealth house international australiaAustralian government therapeutic goods administrationTherapeutic goods administration authorised prescriber schemePrnewswire dragonfly biosciences ltdWorld leading luxuryGrand view researchBiosciences ltdAustralian governmentTherapeutic goods administrationAccess scheme